Akebia continues to publish important, clinically relevant data to further physicians’ understanding of Vafseo® ...

Darbepoetin Alfa is a medication that helps the body produce more red blood cells to treat anaemia caused by kidney failure or chemotherapy. Sheikh Saqer Bin Humaid Al Qasimi, Chairman of the Board, ...

Alfa Romeo may not be the automotive powerhouse it once was, but the automaker is one of the oldest still in existence, dating back to 1910, with its founding in Milan, Italy. That makes Alfa ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today ...

Worsening of hypertension was reported in 14% of VAFSEO and 17% of darbepoetin alfa patients. Serious worsening of hypertension was reported in 2.7% of VAFSEO and 3% of darbepoetin alfa patients.

In this study, vadadustat was noninferior to darbepoetin alfa for efficacy in maintaining hemoglobin levels. For patients with incident dialysis-dependent CKD, the mean differences in the change ...

Darbepoetin alfa (Cresp (25mcg)) is an erythropoiesis-stimulating agent, prescribed for anemia due to chronic kidney disease.It stimulates the bone marrow to produce more red blood cells.

Details concerning the Darbepoetin alfa medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids ...

Pune, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Global “Darbepoetin Alfa Market” research report 2022 is a holistic study of statistical information and provides a comprehensive analysis of the ...